{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-422929","form_type":"8-K","ticker":"TRAX","cik":"0002091349","company_name":"First Tracks Biotherapeutics, Inc.","filed_at":"2026-10-15T20:28:55+00:00","discovered_at":"2026-10-15T20:30:00.256483+00:00","generated_at":"2026-10-15T20:30:03.569987+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"First Tracks Biotherapeutics raises $200M in private placement at $32.75/share","bullets":["Sells 6,106,870 common shares at $32.75/share for ~$200M gross proceeds; closing expected October 19, 2026, subject to customary conditions.","Investors include Affinity Asset Advisors, First Light Asset Management, Sirenia Capital, TCGX, Trails Edge Capital, Vestal Point Capital and mutual funds.","Proceeds intended for general corporate purposes, including clinical development of ANB033, a CD122 antagonist.","Leerink Partners, Piper Sandler, UBS Investment Bank and Wells Fargo Securities acted as placement agents.","Shares issued under Section 4(a)(2); resale registration statement due within 30 days of closing. 35,909,814 shares outstanding as of Oct 12, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-422929","json":"https://secwatch.observer/filing/0001193125-26-422929.json","markdown":"https://secwatch.observer/filing/0001193125-26-422929.md","text":"https://secwatch.observer/filing/0001193125-26-422929.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2091349/000119312526422929/0001193125-26-422929-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2091349/000119312526422929/trax-20261015.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-15T20:30:03.569987+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}